Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1).
Miele L, Perna A, Dajko M, Zocco MA, De Magistris A, Nicoletti TF, Biolato M, Marrone G, Liguori A, Maccora D, Valenza V, Rossi S, Riso V, Di Natale D, Gasbarrini A, Grieco A, Silvestri G. Miele L, et al. Among authors: silvestri g. Dig Liver Dis. 2021 Nov;53(11):1451-1457. doi: 10.1016/j.dld.2020.12.010. Epub 2021 Jan 9. Dig Liver Dis. 2021. PMID: 33436321
Expansion size and presence of CCG/CTC/CGG sequence interruptions in the expanded CTG array are independently associated to hypermethylation at the DMPK locus in myotonic dystrophy type 1 (DM1).
Santoro M, Fontana L, Masciullo M, Bianchi ML, Rossi S, Leoncini E, Novelli G, Botta A, Silvestri G. Santoro M, et al. Among authors: silvestri g. Biochim Biophys Acta. 2015 Dec;1852(12):2645-52. doi: 10.1016/j.bbadis.2015.09.007. Epub 2015 Sep 21. Biochim Biophys Acta. 2015. PMID: 26391753 Free article. No abstract available.
Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.
Bianchi ML, Leoncini E, Masciullo M, Modoni A, Gadalla SM, Massa R, Rastelli E, Terracciano C, Antonini G, Bucci E, Petrucci A, Costanzi S, Santoro M, Boccia S, Silvestri G. Bianchi ML, et al. Among authors: silvestri g. J Neurol. 2016 Mar;263(3):492-8. doi: 10.1007/s00415-015-8006-y. Epub 2016 Jan 6. J Neurol. 2016. PMID: 26739382 Free PMC article.
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.
Perfetti A, Greco S, Cardani R, Fossati B, Cuomo G, Valaperta R, Ambrogi F, Cortese A, Botta A, Mignarri A, Santoro M, Gaetano C, Costa E, Dotti MT, Silvestri G, Massa R, Meola G, Martelli F. Perfetti A, et al. Among authors: silvestri g. Sci Rep. 2016 Dec 1;6:38174. doi: 10.1038/srep38174. Sci Rep. 2016. PMID: 27905532 Free PMC article. Clinical Trial.
Dysautonomia as Onset Symptom of Myotonic Dystrophy Type 2.
Rossi S, Romano A, Modoni A, Perna F, Rizzo V, Santoro M, Monforte M, Pieroni M, Luigetti M, Pomponi MG, Silvestri G. Rossi S, et al. Among authors: silvestri g. Eur Neurol. 2018;79(3-4):166-170. doi: 10.1159/000487508. Epub 2018 Mar 13. Eur Neurol. 2018. PMID: 29533949
1,081 results